- 19 2019/06
iSCLife® products bring new treatments to pat...
The clinical application known as "Clinical study of human umbilical cord mesenchymal stem cells (19#iSCLife®-CSD) for the treatment of uterine traumatic healing failure" with stem cell product has been approved by the state and fully supported by Professor Zhang Weishe, director of the Department of Obstetrics and Gynecology, Xiangya Hospital.
查看详细
- 26 2018/11
® led stem cell international standard moves further to clinical trial" target="_blank" href="/content/details72_1598.html">CCTV4 "China News" reports on a big stem c...
iSCLife® #19 stem cell therapy products enter clinical applications. It is the world's first stem cell project up to international standards to enter the hospital. iSCL stem cell® and iSCLife® stem cell inaugurate a healthy combined development of production, study and research for the benefit of the human shared destiny.
查看详细 - 23 2018/11
® explains a new way of life: iSCL stem cell® seeds, iSCLife® stem cell products for clinical treatment" target="_blank" href="/content/details72_1601.html">Travel TV "For Love"! SCLnow® explain...
SCLnow® cares for every iSCL stem cell® seed and life with awe. Even if the road is full of thorns, still go all out to break open a way through bramble and thistle. Because we are here only to be grateful for life, to be grateful for guarding your purest seed of life. Thank you for being with us all the way to realize stem cell communityofshareddestiny.
查看详细 -
22 2018/11A ray of warm sunshine in the dark, the communi...
In the dark, there is a ray of warm sunshine that illuminates the way forward in the domestic bio-industry. On the stage of setting stem cell international standards, Chinese companies showed up.
查看详细 -
20 2018/11China, even a tiny little cannot be missed!
SCLnow® has always been paving its way forward step by step. China is growing stronger today. Being a Chinese company, SCLnow® has to lay a solid foundation for its own country in the field of stem cells.
查看详细 -
16 2018/11ISO/TC276 international stem cell standard, Rem...
Pluripotent stem cells: The source is very wide, but SCLnow® chose to turn the medical waste of umbilical cord into a treasure of iSCL stem cell® seed. The reason for choosing to extract from umbilical cord is because it is the youngest stem cell with no ethical problem, no pathogenicity, no tumorigenicity.
查看详细
® led stem cell international standard moves further to clinical trial">
® explains a new way of life: iSCL stem cell® seeds, iSCLife® stem cell products for clinical treatment">